Holen Sie sich die Stockscreener-App
0.4374
4.14%
0.0174
Handel nachbörslich:
.43
-0.0074
-1.69%
Schlusskurs vom Vortag:
$0.42
Offen:
$0.416
24-Stunden-Volumen:
1.97M
Relative Volume:
1.18
Marktkapitalisierung:
$17.16M
Einnahmen:
$3.04M
Nettoeinkommen (Verlust:
$-33.97M
KGV:
-0.3289
EPS:
-1.33
Netto-Cashflow:
$-52.47M
1W Leistung:
+2.53%
1M Leistung:
-12.61%
6M Leistung:
-70.64%
1J Leistung:
-86.05%
1-Tages-Spanne:
$0.416
$0.45
1-Wochen-Bereich:
$0.4002
$0.45
52-Wochen-Spanne:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.4374 | 18.60M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-14 | Eingeleitet | Maxim Group | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
What analysts say about Rani Therapeutics Holdings Inc. stockFree Stock Selection - jammulinksnews.com
Is Rani Therapeutics Holdings Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
What drives Rani Therapeutics Holdings Inc. stock priceBreakthrough investment results - jammulinksnews.com
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastSuperior return velocity - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Rani Therapeutics Announces New Securities Purchase Agreement - MSN
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN
Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India
Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN
What makes Rani Therapeutics Holdings Inc. stock price move sharplyLong Term Low Risk Growth - Newser
Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com
How Rani Therapeutics Holdings Inc. stock performs during market volatility10x Return With Managed Risk - Newser
Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa
Rani Therapeutics secures $3 million through registered direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times
Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Rani Therapeutics (NASDAQ:RANI) Shares Up 8.4% – Here’s What Happened - Defense World
The Psychology of Rani Therapeutics Holdings Inc Inc. (RANI) Price Performance: Understanding Market Sentiment - investchronicle.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation - Investing.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation By Investing.com - Investing.com Canada
Rani Therapeutics Surges on Game-Changing Oral Drug Delivery News - RagingBull
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Rani Therapeutics to Present Preclinical Data on RaniPill® Capsule at ENDO 2025 Conference - Nasdaq
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery - GlobeNewswire
Revolutionary Oral GLP-1 Delivery System Matches Injectable Performance: RaniPill's Game-Changing Study Results - Stock Titan
Logitech Announces Date for Release of First Quarter Results for Fiscal Year 2026 - The Globe and Mail
Rani Therapeutics Holdings, Inc.(NasdaqGM:RANI) added to Russell Microcap Growth Index - MarketScreener
Rani Therapeutics Faces Nasdaq Compliance Deadline for Minimum Bid Price Requirement - AInvest
Rani Therapeutics Faces Nasdaq Non-Compliance Notice - TipRanks
291,381 Shares in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Purchased by Two Sigma Investments LP - Defense World
110,163 Shares in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Purchased by Two Sigma Advisers LP - Defense World
Rani Therapeutics announces annual meeting results By Investing.com - Investing.com India
Rani Therapeutics announces annual meeting results - Investing.com
Rani Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):